Astec Life Sciences Limited has responded to a notice from the National Stock Exchange of India (NSE) regarding a significant increase in the volume of its securities across exchanges. The company confirmed its compliance with disclosure requirements under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Astec Life Sciences stated that there are no undisclosed developments that require mandatory disclosure under the Listing Regulations or the Prohibition of Insider Trading Regulations, 2015. The company assured the NSE of its commitment to full compliance with all applicable regulations and to making appropriate disclosures as and when required. The announcement was made by Tejashree Pradhan, Company Secretary & Compliance Officer.
